Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
NRX PharmaceuticalsNRXP -8.26%29 Days Payable is 626.82 as of Mar. 2026, which is 79% below its 10-year median of 3,035.64. GuruFocus rates NRXP with a GF Score™ of 29/100. The stock has 4 warning signs investors should review. Among 702 Biotechnology companies, NRX Pharmaceuticals ranks better than 88.46% on this metric.
The historical rank and industry rank for NRX Pharmaceuticals's Days Payable or its related term are showing as below:
NRXP'
s Days Payable Range Over the Past 10 Years
Min: 1340.93 Med: 3035.64 Max: 3035.64
Current: 1340.93
During the past 6 years, NRX Pharmaceuticals's highest Days Payable was 3035.64. The lowest was 1340.93. And the median was 3035.64.
NRXP's Days Payable is ranked better than 88.46% of 702
companies
in the Biotechnology industry
Industry Median: 113.1
vs NRXP: 1340.93
NRX Pharmaceuticals's Days Payable
increased
from Mar. 2025 (0.00) to Mar. 2026 (626.82).
It may suggest that NRX Pharmaceuticalsdelayed paying its suppliers.
NRX Pharmaceuticals Days Payable Related Terms
NRX Pharmaceuticals Days Payable Historical Data
* Premium members only.
The historical data trend for NRX Pharmaceuticals's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, NRX Pharmaceuticals's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
NRX Pharmaceuticals Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, NRX Pharmaceuticals's Days Payable distribution charts can be found below:
* The bar in red indicates where NRX Pharmaceuticals's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
NRX Pharmaceuticals's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NRX Pharmaceuticals (NRXP) has a Days Payable of 626.82 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NRX Pharmaceuticals and its competitors. This is 79% below median its historical median of 3,035.64. Over the past decade, NRX Pharmaceuticals' Days Payable has ranged from 1,340.93 to 3,035.64. According to the industry distribution chart, NRX Pharmaceuticals ranks #81 out of 702 companies in the Biotechnology industry, placing it in the top 11.5%.
Is NRX Pharmaceuticals' Days Payable too high?
NRX Pharmaceuticals' current Days Payable of 626.82 is 79% below median its 10-year median of 3,035.64. Over the past 10 years, this metric has ranged from a low of 1,340.93 to a high of 3,035.64. The Biotechnology industry median Days Payable is 113.10. NRX Pharmaceuticals' value of 626.82 is 454.2% above this industry median. Based on the distribution chart, NRX Pharmaceuticals ranks #81 out of 702 companies in the Biotechnology industry, which is in the top quartile — a strong position relative to peers. Overall, NRX Pharmaceuticals has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does NRX Pharmaceuticals' Days Payable compare to CRBP and PRQR?
According to the Biotechnology industry distribution chart, NRX Pharmaceuticals ranks #81 out of 702 companies for Days Payable. This places NRX Pharmaceuticals in the top 12% of its industry — outperforming the majority of peers. The industry median Days Payable is 113.10. NRX Pharmaceuticals' value of 626.82 is 454.2% above this benchmark. Historically, NRX Pharmaceuticals' own Days Payable has ranged from 1,340.93 to 3,035.64 over the past decade. While the company's 10-year median is 3,035.64 vs. the industry median of 113.10, NRX Pharmaceuticals has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 113.10, based on 702 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. NRX Pharmaceuticals's current Days Payable of 626.82 is 454.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on NRX Pharmaceuticals and its competitors. For the Biotechnology industry, the median Days Payable is 113.10 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. NRX Pharmaceuticals's current Days Payable is 626.82, which is 79% below median its own 10-year median of 3,035.64. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is NRX Pharmaceuticals stock overvalued right now?
NRX Pharmaceuticals (NRXP) has a current Days Payable of 626.82. The current Days Payable is 626.82, which is 79% below median its 10-year median of 3,035.64 and 454.2% above the Biotechnology industry median of 113.10. NRX Pharmaceuticals' overall GF Score™ is 29/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For NRX Pharmaceuticals (NRXP), the current Days Payable is 626.82 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company is developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
29GF Score
Get the complete analysis for NRXP
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NRXP has been successfully added to your 
